These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25579542)

  • 1. Carvedilol suppresses migration and invasion of malignant breast cells by inactivating Src involving cAMP/PKA and PKCδ signaling pathway.
    Dezong G; Zhongbing M; Qinye F; Zhigang Y
    J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
    Zuo Y; Wu Y; Chakraborty C
    J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c-Src dependent signaling pathway.
    Yu HS; Lin TH; Tang CH
    Prostate; 2013 Jan; 73(1):89-100. PubMed ID: 22653778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation.
    Tang ZN; Zhang F; Tang P; Qi XW; Jiang J
    Oncol Rep; 2011 Nov; 26(5):1243-50. PubMed ID: 21725611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
    Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
    Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells.
    Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
    Toxicon; 2013 Nov; 74():56-67. PubMed ID: 23933586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H; Washington S; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
    Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
    Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
    Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
    Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo-[a]-pyrene induces FAK activation and cell migration in MDA-MB-231 breast cancer cells.
    Castillo-Sanchez R; Villegas-Comonfort S; Galindo-Hernandez O; Gomez R; Salazar EP
    Cell Biol Toxicol; 2013 Aug; 29(4):303-19. PubMed ID: 23955088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
    Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
    Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells.
    Obara Y; Labudda K; Dillon TJ; Stork PJ
    J Cell Sci; 2004 Dec; 117(Pt 25):6085-94. PubMed ID: 15546918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
    Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
    Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
    Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
    J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
    Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
    Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
    Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.